# Lytica Therapeutics, Inc. — Form D

Lytica Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-19. $1.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-19
- Form: D
- Accession: 0002015049-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $1.8M
- Investors: 9
- Date of first sale: 2024-07-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-521884

## Issuer

- Name: Lytica Therapeutics, Inc.
- CIK: 0002015049
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 840 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 617-475-7374

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| JEAN-FRANCOIS DUCREST | Director | CAMBRIDGE, MA |
| JAMES LATORRE | Director | CAMBRIDGE, MA |
| JAMES LATORRE | Executive Officer | CAMBRIDGE, MA |
| DANIEL MACAYA | Director | CAMBRIDGE, MA |
| RIDA MOURTADA | Director | CAMBRIDGE, MA |
| RIDA MOURTADA | Executive Officer | CAMBRIDGE, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-04-11](https://search.stillhousedata.com/formd/0002015049-25-000003) | D | — | $6.0M |
| [2024-03-12](https://search.stillhousedata.com/formd/0002015049-24-000001) | D | — | $4.1M |

## More

- [CIK 2015049 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2015049&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002015049-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.